Terms of the agreement Under the terms of the agreement, Pernix has paid Zogenix $80 million in cash, eliminating the need for a promissory note, and 1,682,086 shares of Pernix common stock, subject to a six …
NASDAQ
Zogenix (NASDAQ: ZGNX) announced today that it intends to offer and sell $60 million of shares of its common stock in an underwritten public offering. Zogenix also expects to grant to the underwriters for the offering a 30 …
ZGNX) from a hold rating to a buy rating in a research report report published on Thursday. They currently have $14.00 price target on the stock. According to Zacks, “Zogenix, Inc. is a pharmaceutical company engaged in …
BNS2mon
Today's Most Active Call & Put Options of the S&P 500 » Evolution Petroleum Corp (AMEX:EPM) saw options trading volume of 556 contracts, representing approximately 55,600 underlying shares or approximately 48.2% …
Zogenix, Inc. (NASDAQ:ZGNX)’s stock has been of interest for both individual investors and Wall Street analysts recently. Let’s look at the crowd and equity research sentiment so that we can get a solid idea as to where …
... from the most recent broker reports is 15.07 The stock increased +0.95% (+0.10) during the last days session, reaching 10.60 and roughly 120667 shares were bought or sold by traders. Zogenix, Inc. is a pharmaceutical …
Trades
ZGNX), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $28 is the highest target while …
Boasting a price of $8.62, Zogenix, Inc. (NASDAQ:ZGNX) traded -7.49% lower on the day. With the last stock
ZGNX) from a hold rating to a strong-buy rating in a research report report published on Wednesday morning. The firm currently has $12.00 price objective on the stock. According to Zacks, “Zogenix, Inc. is a pharmaceutical …
Thecer2mon
Right on the heels of the Food and Drug Administration’s approval of the narcotic painkiller Zohydro, San Diego-based Zogenix Inc. has announced a $60 million public offering of its stock. Shares for the company (Nasdaq: …